French Consortium Investing $104M in Cell Therapy Facility
By Cormac Sheridan
Monday, October 22, 2012
Aided by a generous dollop of government cash, a French consortium of biotechnology companies and academic medical centers is investing €80 million (US$104 million) to develop an industrial-scale facility for the production of cell therapy, including stem cell therapy.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.